Photo of Tom Powles taken from bartscancer.london
May 24, 2024, 00:08
Tom Powles: Mixing papillary and other ‘non-clear cell’ renal cancers guidlines has hampered new treatments
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:
“The ESMO guidlines make a clear distinction between papillary and other ‘non-clear cell’ renal cancers. Mixing these together has hampered new treatments. Sarcomatoid needs upfront PD1 combos. Other subgroups (chromaphobe etc) need more data.”
Further information.
Source: Tom Powles/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 29, 2025, 06:01
Aug 29, 2025, 05:53
Aug 29, 2025, 05:47
Aug 29, 2025, 05:45
Aug 29, 2025, 05:21
Aug 29, 2025, 05:11
Aug 29, 2025, 05:00
Aug 29, 2025, 04:49
Aug 29, 2025, 04:41